Literature DB >> 18452029

Hemocompatibility of poly(ether imide) membranes functionalized with carboxylic groups.

R Tzoneva1, B Seifert, W Albrecht, K Richau, T Groth, A Lendlein.   

Abstract

Materials for blood-contacting applications have to meet high requirements in terms to prevent thrombotic complications after the medical treatment. Surface induced thrombosis, e.g., after application of cardiovascular devices, is linked clearly to the activation of coagulation system and platelet adhesion and activation. The flat sheet poly(ether imide) membrane (PEI) was modified by binding of iminodiacetic acid (IDA) for different periods of time to obtain surfaces with carboxylic (-COOH) groups, namely PEI-1 (modified for 1 min) and PEI-2 (modified for 30 min). The successful binding of the ligands was monitored by thionin acetate assay. The physico-chemical characteristics of the materials were analyzed by SEM, AFM, water contact angle, and Zeta potential measurements. Hemocompatibility of the polymer materials was studied by analyzing the activation of coagulation system (plasma kallikrein-like activity) and platelet adhesion/activation by using immunofluorescence technique. The blood response to PEI membranes was compared to that of a commercial poly(ethylene terephthalate) (PET) membrane. Our results showed that the increase of the negative charges on the modified PEI membrane surfaces (number of -COOH groups) caused a higher contact activation of the coagulation system and a higher rate of platelet adhesion and activation compared to non-modified PEI. However, overall the hemocompatibility of all PEI membranes was higher than that of PET.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452029     DOI: 10.1007/s10856-008-3456-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  25 in total

Review 1.  Structure of heparin and heparin fragments.

Authors:  B Casu
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Antithrombin activation by nonsulfated, non-polysaccharide organic polymer.

Authors:  Bernhard H Monien; Umesh R Desai
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

3.  Contact activation of the plasma coagulation cascade. II. Protein adsorption to procoagulant surfaces.

Authors:  E A Vogler; J C Graper; H W Sugg; L M Lander; W J Brittain
Journal:  J Biomed Mater Res       Date:  1995-08

4.  In vitro hemocompatibility of self-assembled monolayers displaying various functional groups.

Authors:  Claudia Sperling; Rüdiger B Schweiss; Uwe Streller; Carsten Werner
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

5.  Co-adsorbed fibrinogen and von Willebrand factor augment platelet procoagulant activity and spreading.

Authors:  J M Grunkemeier; W B Tsai; T A Horbett
Journal:  J Biomater Sci Polym Ed       Date:  2001       Impact factor: 3.517

6.  Polyetherimide: a new membrane-forming polymer for biomedical applications.

Authors:  B Seifert; G Mihanetzis; T Groth; W Albrecht; K Richau; Y Missirlis; D Paul; G von Sengbusch
Journal:  Artif Organs       Date:  2002-02       Impact factor: 3.094

7.  Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy.

Authors:  E A Vogler; J C Graper; G R Harper; H W Sugg; L M Lander; W J Brittain
Journal:  J Biomed Mater Res       Date:  1995-08

8.  Synthesis and nonthrombogenicity of polyetherurethaneurea film grafted with poly(sodium vinyl sulfonate).

Authors:  Y Ito; Y Iguchi; T Kashiwagi; Y Imanishi
Journal:  J Biomed Mater Res       Date:  1991-11

9.  Structure-biocompatibility relationship of condensation polymers.

Authors:  Y Imai; A Watanabe; E Masuhara; Y Imai
Journal:  J Biomed Mater Res       Date:  1983-11

10.  Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies.

Authors:  N Faucheux; R Schweiss; K Lützow; C Werner; T Groth
Journal:  Biomaterials       Date:  2004-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.